(Q46880764)

26 December 2017

title

Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains (English)

1 reference

26 December 2017

main subject

Sweden

0 references

coronary artery disease

1 reference

5

A Rosengren

1 reference

26 December 2017

author name string

L Björck

1

1 reference

26 December 2017

S Capewell

2

1 reference

26 December 2017

K Bennett

3

1 reference

26 December 2017

G Lappas

4

1 reference

26 December 2017

language of work or name

English

0 references

publication date

13 January 2011

1 reference

26 December 2017

Journal of Internal Medicine

published in

1 reference

26 December 2017

volume

269

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

452-467

1 reference

26 December 2017

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

A critical evaluation of the methodology of the literature on medication compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Potential reductions in United States coronary heart disease mortality by treating more patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Cholesterol-lowering therapy for primary prevention: still much we don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Fibrinolytic treatment for elderly patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

beta Blockade after myocardial infarction: systematic review and meta regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Effectiveness of statin therapy in adults with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Cumulative meta-analysis of therapeutic trials for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Effect of different antilipidemic agents and diets on mortality: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2010.02339.X

10.1111/J.1365-2796.2010.02339.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017